Patents by Inventor Alain Martel

Alain Martel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090202478
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: January 23, 2009
    Publication date: August 13, 2009
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, David R. Langley, Gan Wang, Lawrence G. Hamann
  • Patent number: 7557524
    Abstract: An LED lighting device is provided which is capable of being connected to a network and being controlled by a host computer also connected to the network. The lighting device has several lifespan expanding features such as including several extra LEDs such that as the LEDs of the lighting device degrade over time more LEDs can be turned on thus allowing a constant luminosity to be maintained.
    Type: Grant
    Filed: November 1, 2006
    Date of Patent: July 7, 2009
    Assignee: Gestion Proche Inc.
    Inventors: Daniel Chevalier, Alain Martel
  • Publication number: 20090068140
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: February 13, 2008
    Publication date: March 12, 2009
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, David R. Langley, Gan Wang, Lawrence G. Hamann
  • Patent number: 7470713
    Abstract: The present invention provides compounds having formula I and their use for the treatment of cancer.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: December 30, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Anne Marinier, Stephan Roy, Alain Martel
  • Publication number: 20080311075
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: May 14, 2008
    Publication date: December 18, 2008
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Lawrence G. Hamann, Clint A. James, David R. Langley, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Gan Wang, Fukang Yang
  • Publication number: 20080299075
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: February 12, 2008
    Publication date: December 4, 2008
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, David R. Langley, Gan Wang, Lawrence G. Hamann
  • Publication number: 20080050336
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: August 8, 2007
    Publication date: February 28, 2008
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, David R. Langley, Gan Wang, Lawrence G. Hamann
  • Publication number: 20080044380
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: August 8, 2007
    Publication date: February 21, 2008
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, David R. Langley, Lawrence G. Hamann
  • Publication number: 20080044379
    Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
    Type: Application
    Filed: August 8, 2007
    Publication date: February 21, 2008
    Inventors: Carol Bachand, Makonen Belema, Daniel H. Deon, Andrew C. Good, Jason Goodrich, Clint A. James, Rico Lavoie, Omar D. Lopez, Alain Martel, Nicholas A. Meanwell, Van N. Nguyen, Jeffrey Lee Romine, Edward H. Ruediger, Lawrence B. Snyder, Denis R. St. Laurent, Fukang Yang, David R. Langley, Lawrence G. Hamann
  • Publication number: 20070211463
    Abstract: An LED lighting device is provided which is capable of being connected to a network and being controlled by a host computer also connected to the network. The lighting device has several lifespan expanding features such as including several extra LEDs such that as the LEDs of the lighting device degrade over time more LEDs can be turned on thus allowing a constant luminosity to be maintained.
    Type: Application
    Filed: November 1, 2006
    Publication date: September 13, 2007
    Inventors: Daniel Chevalier, Alain Martel
  • Publication number: 20070139317
    Abstract: A luminaire comprising an electric circuit element for a lighting system. The electric circuit element comprises an LED electric circuit assembly. The LED electric circuit assembly comprises one or more current regulated LED strings or chains. Each of the LED strings or chains comprises a respective current regulator and one or more LEDs linked in series with a respective current regulator. The LED electric circuit assembly is configured such that when the LED electric circuit assembly comprises two or more LED strings or chains, the two or more LED strings or chains are linked in parallel.
    Type: Application
    Filed: April 7, 2006
    Publication date: June 21, 2007
    Inventors: Alain Martel, Daniel Chevalier
  • Publication number: 20060091827
    Abstract: An LED lighting device is provided which is capable of being connected to a network and being controlled by a host computer also connected to the network. The lighting device has several lifespan expanding features such as including several extra LEDs such that as the LEDs of the lighting device degrade over time more LEDs can be turned on thus allowing a constant luminosity to be maintained.
    Type: Application
    Filed: January 21, 2005
    Publication date: May 4, 2006
    Inventors: Daniel Chevalier, Alain Martel
  • Publication number: 20050187218
    Abstract: The present invention provides compounds having Formula I and their use for the treatment of cancer.
    Type: Application
    Filed: February 18, 2005
    Publication date: August 25, 2005
    Inventors: Anne Marinier, Stephan Roy, Alain Martel
  • Patent number: 6933294
    Abstract: Compounds having the formula (I), and pharmaceutically-acceptable salts, hydrates and prodrugs thereof, are useful as anti-inflammatory agents, in which R1, R2, and R3 are hydrogen, halogen, alkyl, or perfluoroalkyl; R4 is an optionally substituted alkyl or cycloalkyl group; X is a linker; A is an aryl, heteroaryl, heterocycle, cycloalkyl, or is absent; and R7 is a substituent on A as defined in the specification.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: August 23, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Makonen Belema, Amy Bunker, Van Nguyen, Francis Beaulieu, Carl Ouellet, Anne Marinier, Stephan Roy, Xuejie Yang, Yuping Qiu, Yunhui Zhang, Alain Martel, Christopher Zusi
  • Patent number: 6924391
    Abstract: Inhibitors of the cytosolic phospholypase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formula wherein X, Z, X1, R1, R2, Ra, Rb, R3, R4 and Y are as defined in the specification.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: August 2, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jacques Banville, Roger Remillard, Neelakantan Balasubramanian, Gilles Bouthillier, Alain Martel
  • Publication number: 20050122064
    Abstract: An LED lighting device is provided which is capable of being connected to a network and being controlled by a host computer also connected to the network. The lighting device has several lifespan expanding features such as including several extra LEDs such that as the LEDs of the lighting device degrade over time more LEDs can be turned on thus allowing a constant luminosity to be maintained.
    Type: Application
    Filed: January 21, 2005
    Publication date: June 9, 2005
    Inventors: Daniel Chevalier, Alain Martel
  • Publication number: 20040058930
    Abstract: Compounds having the formula (I), 1
    Type: Application
    Filed: March 27, 2003
    Publication date: March 25, 2004
    Inventors: Makonen Belema, Amy Bunker, Van Nguyen, Francis Beaulieu, Carl Ouellet, Anne Marinier, Stephan Roy, Xuejie Yang, Yuping Qiu, Yunhui Zhang, Alain Martel, Christopher Zusi
  • Publication number: 20020140379
    Abstract: An LED lighting device is provided which is capable of being connected to a network and being controlled by a host computer also connected to the network. The lighting device has several lifespan expanding features such as including several extra LEDs such that as the LEDs of the lighting device degrade over time more LEDs can be turned on thus allowing a constant luminosity to be maintained.
    Type: Application
    Filed: December 19, 2001
    Publication date: October 3, 2002
    Inventors: Daniel Chevalier, Alain Martel
  • Publication number: 20020037875
    Abstract: Inhibitors of the cytosolic phospholypase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases.
    Type: Application
    Filed: May 3, 2001
    Publication date: March 28, 2002
    Inventors: Jacques Banville, Roger Remillard, Neelakantan Balasubramanian, Gilles Bouthillier, Alain Martel
  • Patent number: D560803
    Type: Grant
    Filed: May 8, 2006
    Date of Patent: January 29, 2008
    Assignee: Cryocath Technologies Inc.
    Inventors: Daniel Tassé, Alain Martel, Lucie Laforest